Literature DB >> 27681433

MALT1 Protease Activation Triggers Acute Disruption of Endothelial Barrier Integrity via CYLD Cleavage.

Linda R Klei1, Dong Hu1, Robert Panek2, Danielle N Alfano1, Rachel E Bridwell1, Kelly M Bailey3, Katherine I Oravecz-Wilson2, Vincent J Concel1, Emily M Hess1, Matthew Van Beek2, Phillip C Delekta2, Shufang Gu2, Simon C Watkins4, Adrian T Ting5, Peter J Gough6, Kevin P Foley6, John Bertin6, Linda M McAllister-Lucas7, Peter C Lucas8.   

Abstract

Microvascular endothelial cells maintain a tight barrier to prevent passage of plasma and circulating immune cells into the extravascular tissue compartment, yet endothelial cells respond rapidly to vasoactive substances, including thrombin, allowing transient paracellular permeability. This response is a cornerstone of acute inflammation, but the mechanisms responsible are still incompletely understood. Here, we demonstrate that thrombin triggers MALT1 to proteolytically cleave cylindromatosis (CYLD). Fragmentation of CYLD results in microtubule disruption and a cascade of events leading to endothelial cell retraction and an acute permeability response. This finding reveals an unexpected role for the MALT1 protease, which previously has been viewed mostly as a driver of pro-inflammatory NF-κB signaling in lymphocytes. Thus, MALT1 not only promotes immune cell activation but also acutely regulates endothelial cell biology, actions that together facilitate tissue inflammation. Pharmacologic inhibition of MALT1 may therefore have synergistic impact by targeting multiple disparate steps in the overall inflammatory response.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bcl10; CARD10; CARMA3; CYLD; G protein-coupled receptor (GPCR); MALT1 protease; NF-κB; Protease activated receptor-1 (PAR1); endothelial permeability; thrombin

Mesh:

Substances:

Year:  2016        PMID: 27681433      PMCID: PMC5087334          DOI: 10.1016/j.celrep.2016.08.080

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  62 in total

1.  The proteolytic activity of the paracaspase MALT1 is key in T cell activation.

Authors:  Fabien Rebeaud; Stephan Hailfinger; Anita Posevitz-Fejfar; Myriam Tapernoux; Roger Moser; Daniel Rueda; Olivier Gaide; Montserrat Guzzardi; Emanuela M Iancu; Nathalie Rufer; Nicolas Fasel; Margot Thome
Journal:  Nat Immunol       Date:  2008-02-10       Impact factor: 25.606

Review 2.  CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.

Authors:  S-C Sun
Journal:  Cell Death Differ       Date:  2010-01       Impact factor: 15.828

3.  Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3·Bcl10·MALT1 signalosome.

Authors:  Phillip C Delekta; Ingrid J Apel; Shufang Gu; Katy Siu; Yoshiyuki Hattori; Linda M McAllister-Lucas; Peter C Lucas
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

4.  MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo.

Authors:  Lorena Fontan; Chenghua Yang; Venkataraman Kabaleeswaran; Laurent Volpon; Michael J Osborne; Elena Beltran; Monica Garcia; Leandro Cerchietti; Rita Shaknovich; Shao Ning Yang; Fang Fang; Randy D Gascoyne; Jose Angel Martinez-Climent; J Fraser Glickman; Katherine Borden; Hao Wu; Ari Melnick
Journal:  Cancer Cell       Date:  2012-12-11       Impact factor: 31.743

5.  plusTipTracker: Quantitative image analysis software for the measurement of microtubule dynamics.

Authors:  Kathryn T Applegate; Sebastien Besson; Alexandre Matov; Maria H Bagonis; Khuloud Jaqaman; Gaudenz Danuser
Journal:  J Struct Biol       Date:  2011-07-29       Impact factor: 2.867

6.  CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells.

Authors:  Linda M McAllister-Lucas; Jürgen Ruland; Katy Siu; Xiaohong Jin; Shufang Gu; David S L Kim; Peter Kuffa; Dawn Kohrt; Tak W Mak; Gabriel Nuñez; Peter C Lucas
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-13       Impact factor: 11.205

Review 7.  The roles of proteinase-activated receptors in the vascular physiology and pathophysiology.

Authors:  Katsuya Hirano
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-11-09       Impact factor: 8.311

8.  CYLD regulates spindle orientation by stabilizing astral microtubules and promoting dishevelled-NuMA-dynein/dynactin complex formation.

Authors:  Yunfan Yang; Min Liu; Dengwen Li; Jie Ran; Jinmin Gao; Shaojun Suo; Shao-Cong Sun; Jun Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

9.  'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage.

Authors:  Nicole C Kaneider; Andrew J Leger; Anika Agarwal; Nga Nguyen; George Perides; Claudia Derian; Lidija Covic; Athan Kuliopulos
Journal:  Nat Immunol       Date:  2007-10-28       Impact factor: 25.606

10.  Microtubule depolymerization rapidly collapses capillary tube networks in vitro and angiogenic vessels in vivo through the small GTPase Rho.

Authors:  Kayla J Bayless; George E Davis
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

View more
  17 in total

Review 1.  Limiting inflammation-the negative regulation of NF-κB and the NLRP3 inflammasome.

Authors:  Inna S Afonina; Zhenyu Zhong; Michael Karin; Rudi Beyaert
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

Review 2.  CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different.

Authors:  Marie Lork; Kelly Verhelst; Rudi Beyaert
Journal:  Cell Death Differ       Date:  2017-03-31       Impact factor: 15.828

3.  Pharmacological inhibition of MALT1 protease activity suppresses endothelial activation via enhancing MCPIP1 expression.

Authors:  Yong Li; Shengping Huang; Xuan Huang; Xiuzhen Li; Adrian Falcon; Adele Soutar; Frederic Bornancin; Zhisheng Jiang; Hong-Bo Xin; Mingui Fu
Journal:  Cell Signal       Date:  2018-06-18       Impact factor: 4.315

4.  GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoprotein.

Authors:  Jing Cheng; Linda R Klei; Nathaniel E Hubel; Ming Zhang; Rebekka Schairer; Lisa M Maurer; Hanna B Klei; Heejae Kang; Vincent J Concel; Phillip C Delekta; Eric V Dang; Michelle A Mintz; Mathijs Baens; Jason G Cyster; Narayanan Parameswaran; Margot Thome; Peter C Lucas; Linda M McAllister-Lucas
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

5.  Malt1 Protease Deficiency in Mice Disrupts Immune Homeostasis at Environmental Barriers and Drives Systemic T Cell-Mediated Autoimmunity.

Authors:  Kea Martin; Ratiba Touil; Yeter Kolb; Grozdan Cvijetic; Kiichi Murakami; Laura Israel; Fernanda Duraes; David Buffet; Anton Glück; Satoru Niwa; Marc Bigaud; Tobias Junt; Natasa Zamurovic; Philip Smith; Kathy D McCoy; Pamela S Ohashi; Frédéric Bornancin; Thomas Calzascia
Journal:  J Immunol       Date:  2019-10-28       Impact factor: 5.422

6.  MALT1 targeting suppresses CARD14-induced psoriatic dermatitis in mice.

Authors:  Inna S Afonina; Rudi Beyaert; Elien Van Nuffel; Jens Staal; Griet Baudelet; Mira Haegman; Yasmine Driege; Tino Hochepied
Journal:  EMBO Rep       Date:  2020-04-28       Impact factor: 8.807

7.  Enhanced endothelial barrier function by monoclonal antibody activation of vascular endothelial cadherin.

Authors:  Ki-Sook Park; Leslayann Schecterson; Barry M Gumbiner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-02-12       Impact factor: 4.733

8.  Central role of myeloid MCPIP1 in protecting against LPS-induced inflammation and lung injury.

Authors:  Yong Li; Xuan Huang; Shengping Huang; Hui He; Tianhua Lei; Fatma Saaoud; Xiao-Qiang Yu; Ari Melnick; Anil Kumar; Christopher J Papasian; Daping Fan; Mingui Fu
Journal:  Signal Transduct Target Ther       Date:  2017-12-08

9.  Salvianolic Acid A Inhibits OX-LDL Effects on Exacerbating Choroidal Neovascularization via Downregulating CYLD.

Authors:  Ke Mao; Wanting Shu; Libin Liu; Qing Gu; Qinghua Qiu; XingWei Wu
Journal:  Oxid Med Cell Longev       Date:  2017-09-01       Impact factor: 6.543

Review 10.  CARMA3 Is a Critical Mediator of G Protein-Coupled Receptor and Receptor Tyrosine Kinase-Driven Solid Tumor Pathogenesis.

Authors:  J Randall McAuley; Tanner J Freeman; Prasanna Ekambaram; Peter C Lucas; Linda M McAllister-Lucas
Journal:  Front Immunol       Date:  2018-08-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.